UK Meningitis Outbreak: Cases Rise, Vaccinations Urged | Latest Updates

The number of confirmed and suspected cases of meningitis in the United Kingdom, particularly affecting students, continues to rise, prompting long queues for vaccinations. As of today, March 22, 2026, health officials report 34 cases linked to an outbreak centered in Kent, with two fatalities – an 18-year-old woman, Juliette Kenny, and a 21-year-old University of Kent student. This surge has triggered a public health response focused on vaccination and preventative antibiotic treatment for those potentially exposed.

Understanding Meningitis and the Current Outbreak

Meningitis is an inflammation of the membranes surrounding the brain and spinal cord. It can be caused by several different pathogens, including bacteria, viruses, and fungi. Bacterial meningitis is particularly serious and can lead to severe complications, including brain damage, hearing loss, and even death. The current outbreak in the UK is caused by Meningitis B (MenB), the most common cause of meningococcal meningitis in the country. The Meningitis Research Foundation is working with the family of Juliette Kenny to advocate for broader access to the MenB vaccine.

The outbreak appears to have originated at Club Chemistry in Canterbury, with cases identified between March 5th and 15th. The UK Health Security Agency (UKHSA) initially offered vaccinations to students at the University of Kent living in halls of residence, but has since expanded eligibility to include all students and staff at the University of Kent, students at Canterbury Christ Church University, and Year 12 and 13 pupils at schools with confirmed or probable cases. Anyone who attended Club Chemistry during the specified period is also being offered vaccination, as are those who have been offered preventative antibiotics by the UKHSA. The BBC reports that the number of confirmed or suspected cases rose from 27 to 29 on Friday, March 20th, and now stands at 34.

Juliette Kenny’s Legacy: A Call for Expanded Vaccination

The death of Juliette Kenny, who died just a day after experiencing symptoms of vomiting and discolouration in her cheeks, has brought renewed urgency to the call for wider access to the MenB vaccine. Her father, Michael Kenny, described her as “a force in this world” and emphasized that the illness “could be avoided.” The Kenny family is urging the government to extend routine NHS access to the MenB vaccine to teenagers and young adults, as current routine vaccinations only began in 2015. This means that many students and young adults are not currently protected. The Standard details the family’s plea for lasting change in response to this tragedy.

The MenB Vaccine and Current UK Policy

The MenB vaccine, Bexsero, was introduced into the UK’s routine childhood immunization schedule in September 2015, offering protection to infants. However, the Joint Committee on Vaccination and Immunisation (JCVI) has not yet recommended routine vaccination for older teenagers and young adults. This decision is based on a complex assessment of cost-effectiveness and the potential impact on disease burden. The current focus is on targeted vaccination of those at highest risk during this outbreak.

What to Do If You Suspect Meningitis

It’s crucial to be aware of the symptoms of meningitis, which can include a high fever, severe headache, stiff neck, vomiting, sensitivity to light, and a rash that doesn’t fade when pressed. However, symptoms can vary, and not everyone will experience all of them. If you or someone you realize is experiencing these symptoms, it is essential to seek immediate medical attention. Do not wait for a rash to appear. Early diagnosis and treatment are critical for improving outcomes.

Public Health Response and Ongoing Surveillance

The UKHSA is closely monitoring the situation and working to identify and contact individuals who may have been exposed. The agency is also investigating the potential cause of the outbreak and whether a particular strain of the bacteria is responsible. The fact that the outbreak is described as “explosive” suggests a rapid increase in cases, requiring a swift and coordinated response. Health officials are keeping a “close eye” on the spread of the disease, with expectations that the number of cases may continue to rise in the short term. RTL News reports that the outbreak has now spread to London.

Looking Ahead: Vaccine Review and Future Guidance

The current outbreak is likely to prompt a review of the JCVI’s recommendations regarding MenB vaccination for teenagers and young adults. The committee will consider the latest data on disease incidence, vaccine effectiveness, and cost-effectiveness. Any changes to the vaccination schedule would be based on a thorough assessment of the evidence and a careful consideration of the potential benefits and risks. In the meantime, public health officials are urging anyone eligible for vaccination to take advantage of the opportunity. Continued surveillance and monitoring will be essential to track the spread of the outbreak and inform future public health interventions.